"PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to … – SBWire (press release)
|
“PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to …
SBWire (press release) Boston, MA — (SBWIRE) — 08/15/2013 — GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to 2022″. The chronic heart failure (CHF) market is a mature market that has been slowly … |
